<h3 id="key-highlights">Key Highlights</h3>
<ul>
 <li>STOXX 600 climbed 0.3% on Friday, marking its fourth consecutive week of record-breaking performance</li>
 <li>Healthcare sector dominated with a 1.8% gain, featuring Genmab’s impressive 9.6% surge following robust earnings</li>
 <li>Kingspan shares skyrocketed more than 15% after upgrading profit guidance amid explosive data centre demand</li>
 <li>Q2 earnings projections for European firms now exceed 22%, representing the most robust growth since Q3 2022</li>
 <li>Investor sentiment remained measured before US employment figures, while climbing oil prices heightened inflation worries</li>
</ul>
European equity markets closed out the opening week of August with impressive momentum, as both the STOXX 600 and STOXX 50 indices registered record territory for their fourth straight week.
By mid-morning Friday, the STOXX 600 had advanced 0.3% to reach 659.91 points. Meanwhile, the STOXX 50 posted a 0.2% daily increase and concluded the week with a robust 2.4% gain.
<figure style="width: 100%" class="wp-caption aligncenter">
 [[IMG_0]] 
 <figcaption><a href="https://finance.yahoo.com/quote/%5ESTOXX/" rel="noopener noreferrer nofollow">STXE 600 I (^STOXX)</a>
 </figcaption>
</figure>
The primary catalyst behind these advances was an active earnings reporting period. Based on LSEG analytics, companies comprising the index are projected to deliver second-quarter earnings expansion exceeding 22%. This would represent the most significant growth rate observed since the third quarter of 2022.
<h3 id="healthcare-sector-dominates-friday-trading">Healthcare Sector Dominates Friday Trading</h3>
The healthcare sector emerged as Friday’s champion, registering a 1.8% advance. Genmab spearheaded the rally with a remarkable 9.6% climb following the oncology specialist’s announcement of elevated first-half revenues and an improved annual forecast.
<a href="https://coincentral.com/novo-nordisk-nvo-stock-plunges-9-after-zeus-heart-trial-misses-key-goal/" rel="noopener noreferrer nofollow">Novo Nordisk</a>, Abivax, and Zealand Pharma collectively delivered returns ranging from 3.4% to 4.6%.
SAP experienced nearly 3% appreciation, while Rheinmetall contributed a 2% increase. Novartis climbed 1%, AstraZeneca advanced 1.6%, and Airbus registered a 0.8% gain.
Czech defence manufacturer CSG inched upward by 1.3% following a first-half revenue report that surpassed analyst projections, bolstered by robust ammunition sales. The wider aerospace and defence sector rose 0.9% on the session and appeared positioned to become the week’s strongest performer, climbing 5.8%.
<h3 id="kingspan-s-data-centre-momentum-takes-centre-stage">Kingspan’s Data Centre Momentum Takes Centre Stage</h3>
Kingspan emerged as the session’s star performer, rocketing more than 15% higher after the construction materials company elevated its annual profit projections. The firm attributed the revision to surging demand from the data centre sector.
However, not all companies celebrated. Munich Re declined 2.7% notwithstanding a second-quarter net profit report showing 6% growth that exceeded market expectations. Stellantis tumbled 2.5% following a downgrade to underperform from Bernstein analysts.
Geopolitical developments in the Middle East also captured market attention. <a href="https://coincentral.com/iran-moves-to-ban-u-s-and-israeli-ships-from-strait-of-hormuz-as-oil-prices-rise/" rel="noopener noreferrer nofollow">Brent crude futures</a> climbed to $83.17 per barrel amid fresh concerns surrounding the Strait of Hormuz, following Iran’s proposal to restrict certain vessels from the strategic waterway.
On the economic data front, Germany delivered encouraging news with industrial production and export statistics exceeding forecasts.
Market participants exercised prudence ahead of the upcoming US employment report, recognizing that robust job numbers could reinforce the Federal Reserve’s rationale for maintaining current interest rates.
According to Gordon Kerr, European macro strategist at KBRA, earnings results are validating the strength of European corporate fundamentals, though he cautioned that markets are growing increasingly discriminating as elevated valuations create diminished tolerance for underperformance.
The STOXX 600 concluded the week with a 1.4% advance.
The post <a href="https://blockonomi.com/european-markets-surge-to-new-record-highs-for-fourth-consecutive-week/" rel="noopener noreferrer nofollow">European Markets Surge to New Record Highs for Fourth Consecutive Week</a> appeared first on <a href="https://blockonomi.com" rel="noopener noreferrer nofollow">Blockonomi</a>.

European Markets Surge to New Record Highs for Fourth Consecutive Week

Table of Contents

Blockonomi

Other articles published on Aug 7, 2026

Join our free newsletter for daily crypto updates!